Molecular imaging is a field of medical imaging that focuses on imaging molecules of medical interest within living patients. Molecular imaging procedures are non-invasive, safe and painless, and are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer’s and Parkinson’s disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more. Gen Consulting Company estimates the global molecular imaging market will total USD 12,165 百万 2028, 平均每年增长 5.9 预测期内的百分比, according to the latest edition of the Global Molecular Imaging Market Report.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global molecular imaging market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the molecular imaging industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对组件的详细分析, 应用, 最终用户, 和地区. The global market for molecular imaging can be segmented by component: imaging agents, imaging software, imaging systems. The imaging agents segment was the largest contributor to the global molecular imaging market in 2021. Molecular imaging market is further segmented by application: clinical applications, preclinical research. 基于最终用户, the molecular imaging market is segmented into: 门诊手术中心 (ASC), 医院, speciality clinics, 其他的. 根据地区, the molecular imaging market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

按成分:
– imaging agents
– imaging software
– imaging systems

按申请:
– clinical applications
– preclinical research

按最终用户:
– 门诊手术中心 (ASC)
– 医院
– speciality clinics
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The imaging systems market is further segmented into magnetic resonance spectroscopy, multimodality imaging, optical imaging, radionuclide imaging, ultrasound molecular imaging. The multimodality imaging segment is estimated to account for the largest share of the global molecular imaging market. 此外, the imaging agents market has been categorized into antibodies, aptamers, peptides, 小分子. The peptides segment held the largest share of the global molecular imaging market in 2021 预计在预测期内将持有其份额.

The report also provides analysis of the key companies of the industry and their detailed company profiles including Bayer AG, 布鲁克公司, 佳能医疗系统公司, 康德乐, 公司, CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, Esaote SpA, 通用电气医疗集团, Guerbet SA, 皇家飞利浦公司, Mediso Ltd., MiE Medical Imaging Electronics GmbH, Neusoft Corporation, 诺华国际公司, 珀金埃尔默, 公司, 岛津制作所, Siemens Healthineers AG, Spectrum Dynamics Medical, 公司, United Imaging Healthcare Co., 有限公司, Vieworks Co., 有限公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global molecular imaging market.
– To classify and forecast the global molecular imaging market based on component, 应用, 最终用户, 地区.
– To identify drivers and challenges for the global molecular imaging market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global molecular imaging market.
– To identify and analyze the profile of leading players operating in the global molecular imaging market.

为什么选择这份报告
– Gain a reliable outlook of the global molecular imaging market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.